Blog
News & Updates
Stay updated with Dei BioPharma’s latest breakthroughs, milestones, and industry insights in pharmaceutical innovation.
Dei BioPharma Founder Dr. Magoola wins prestigious Molecular Biologist Award for his mRNA cutting edge vaccines research
Dr. Matthias Magoola Recognized at International Molecular Biologist Awards for Vaccine Research KAMPALA – Recognition for Groundbreaking Work in mRNA...
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis
PUBLICATION BY DR. MATTHIAS MAGOOLA, CHEMIST Abstract MicroRNAs (miRNAs) play a crucial role in maintaining cellular homeostasis by binding to...
We are hiring
Job Application Instructions – Dei BioPharma Ltd How to Apply:Applications should be sent via email to recruitment@deibiopharma.com with the JOB...
Parliament’s Health Committee urges Dei BioPharma to save Uganda from emerging tropical diseases
MPs Urge Dei Biopharma to Accelerate Production of Life-Saving Medicines KAMPALA, September 29, 2024 – Members of Parliament on the...
Opposition MPs impressed by progress at Dei BioPharma’s manufacturing plant
Opposition Leader Joel Ssenyonyi Visits Dei BioPharma Facility in Matugga MATUGGA, September 19, 2024 – The sun shone brightly over...
Dei BioPharma wins top Africa accolade
KAMPALA – Dei BioPharma Wins Best Pharma Company at African Excellence Awards Dei BioPharma, Uganda’s first research-based biotechnology and pharmaceuticals...
Dei Biopharma gets NDA clearance for drug manufacturing
The National Drug Authority (NDA) has granted Dei Biopharma Limited a landmark license to manufacture drugs at its Matugga premises....
Synergistic Approaches in Neurodegenerative Therapeutics: 2 Multi-Target Drug Innovative Interventions for Alzheimer’s 3 Disease
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative disorders, even...
mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract Recombinant technology has been around for nearly three-quarters of a century and has revolutionized...